Publications


Peer Reviewed Publications

  1. Douglas KP, Bluth EL, Sauter ER, McKinnon WMP, Bergeron R, Merritt C: Radiographic evaluation of the augmented breast. South Med J 84:49-54, 1991.
  2. Sauter ER, Hollier LH, Farr GH: The value of flow cytometric analysis in multicentric glomus tumors of the head and neck. Cancer 69:1452-1456, 1992.
  3. Sauter ER, Eisenberg BL, Hoffman JP, Ottery FD, Boraas MC, Goldstein LJ, Solin LJ: Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer. World J Surg 17:237-242, 1993.
  4. Sauter ER, Hoffman JP, Ottery FD, Kowalyshyn MJ, Litwin S, Eisenberg BL: Is frozen section analysis of lumpectomy margins worthwhile? Cancer 73:2609-2612, 1994.
  5. Sauter ER, Daly M, Linahan K, Ehya H, Engstrom PF, Bonney G, Ross E, Yu H, Diamandis E: Prostate specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev 5:967-970, 1996.
  6. Sauter ER, Ross E, Daly M, Klein-Szanto A, Engstrom PF, Sorling A, Malick J, Ehya H: Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer 76:494-501, 1997.
  7. Zarghami N, Grass L, Sauter ER, Diamandis EP: Prostate specific antigen level in serum during the menstrual cycle: possible regulation by progesterone. Clin Chem 43:1862-1867, 1997.
  8. Sauter ER, Daly M, Engstrom PF, Ehya H, Diamandis E: Prostate-specific antigen (PSA) production in the female breast: association with progesterone. Cancer Epidemiol Biomarkers Prev 7:315-320, 1998.
  9. Sauter ER, Ehya H, Babb J, Diamandis E, Daly M, Klein-Szanto A, Sigurdson E, Hoffman J, Malick J, Engstrom PF. Biologic markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br J Cancer 81:1222-1227, 1999.
  10. Black MH, Magklara A, Obiezu C, Levesque MA, Sutherland DJA, Tindall DJ, Young CYF, Sauter ER, Diamandis EP. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumors and in normal breast secretions. Br J Cancer 82:361-367, 2000.
  11. Mitchell G, Trott PA, Morris L, Coleman N, Sauter E, Eeles RA. Cellular characteristics of nipple aspiration fluid during the menstrual cycle in healthy premenopausal women. Cytopathology 12:184-196, 2001.
  12. Sauter ER, Diamandis EP. Nipple fluid carcinoembryonic antigen (CEA) and prostate-specific antigen (PSA) in cancer-bearing and tumor-free breasts [correspondence]. J Clin Oncol 19:3160, 2001.
  13. Sauter ER, Ehya H, Mammen A, Klein G. Nipple Aspirate Cytology and Pathologic Parameters Predict Residual Cancer and Nodal Involvement After Excisional Breast Biopsy. Br J Cancer 85:1952-1957, 2001.
  14. Sauter ER, Tichansky DS, Chervoneva I, Diamandis EP. Circulating testosterone and PSA in NAF and tissue are associated with breast cancer. Environmental Health Perspectives 110:241-246, 2002.
  15. Sauter ER, Chervoneva I, Diamandis A, Khosravi JM, Litwin S, Diamandis EP. PSA and IGFBP-3 in NAF are associated with breast cancer. Cancer Detection & Prevention 26:149-157, 2002.
  16. Sauter ER, Zhu W, Fan X-J, Wassell RP, Chervoneva I, Du Bois, GC. Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer. Br J Cancer 86:1440-1443, 2002.
  17. Hsiung R, Zhu W, Klein G, Qin W, Rosenberg A, Park P, Rosato E, Sauter ER. High basic fibroblast growth factor levels in nipple aspirate fluid are correlated with breast cancer. The Cancer Journal 8:303-310, 2002.
  18. Sauter ER, Welch T, Magklara A, Klein G, Diamandis EP. Ethnic variation in kallikrein expression in nipple aspirate fluid. Int J Cancer 100:678-682, 2002.

Abstracts

  1. Sauter E, McKinnon WMP: Does augmentation mammaplasty affect the subsequent formation of breast cancer? 56th Annual Assembly SE Surg Congress, 1988.
  2. Sauter ER, Bolton JS, McKinnon WMP, Lemon-Allen S, Sardi A: Do all patients with node negative breast cancer need adjuvant therapy? Papers Session, 76th Clinical Congress Am College of Surgeons, 1990.
  3. Sauter ER, Hoffman JP, Ottery FD, Kowalyshyn MJ, Litwin S, Eisenberg BL: Is frozen section analysis of reexcision lumpectomy margins worthwhile? Proc Am Radium Soc 75:25A, 1993.
  4. Sauter E, Coia L, Eisenberg B, Hanks G: Growth factor expression as a potential survival prognosticator in patients with esophageal adenocarcinoma receiving high dose radiation and chemotherapy. Int J Rad Oncol Biol Phys 27:141A, 1993.
  5. Sauter ER, Ridge JA, Trock B, Cleveland D, Whitley KV, Mohr RM, Klein-Szanto, AJP: p53 overexpression in primary and metastatic head and neck carcinomas. Proc Am Assoc Cancer Res 35:1407A, 1994.
  6. Klein-Szanto AJP, Mitsunaga S, Zhang SY, Sauter ER, Kley N, Bianchi A: Similar abnormalities of the p53 and NF-2 genes in rodent and human tumors. Intl Workshop on Human and Experimental Skin Carcinogenesis, pp. 28 and 29, May 1994.
  7. Fortunato L, Clair M, Hoffman J, Sigurdson ER, Sauter ER, Eisenberg B: Is CT portography (CTP) really useful in patients who undergo intraoperative ultrasonography (IOUS)? 37th Annual Meeting, Midwest Surgical Assoc, 1994.
  8. Sauter E, Mandel J, Keller S: p53 correlates with disease progression in patients with non-small cell lung cancer. 48th Cancer Symposium, Soc Surg Oncol, 1995.
  9. Gandour-Edwards R, Trock B, Sauter ER, Klein-Szanto A: p53, Hsp27 and IL-6 in head and neck squamous cell carcinomas. Annual Mtg Intl Academy of Pathologists, 1995.
  10. Sauter ER, Ehya H, Klein-Szanto A, Sorling A, Engstrom P, Jones T, Daly MB: Nipple aspirate cytology in women at high risk for breast cancer. Proc Am Assoc Cancer Res 36:1216A, 1995.
  11. Trock BJ, Goodrow TL, Cleveland D, Sauter E, Ridge A, et al: Multifactoral assessment of gene mutations in squamous cell carcinomas of the head and neck. Proc Am Assoc Cancer Res 36:1698A, 1995.
  12. Sauter ER, Ehya H, Klein-Szanto AJP, Engstrom PF, Sorling A, Linahan K, Daly M, Ross E: Nipple aspirate fluid: A promising noninvasive method to identify markers of breast cancer risk. Proc Am Assoc Cancer Res 37:1457A, 1996.
  13. Sauter ER, Daly M, Linahan K, Ehya H, Engstrom PF, Sorling A, Bonney G, Ross E, Yu H, Diamandis EP: Prostate specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Proc Am Assoc Cancer Res 37:1458A, 1996.
  14. Langer C, Schaebler D, Sauter E, DeMaria D, Reilly D, Ridge J, O'Dwyer P, Ozols R: Phase II study of PALA (N-phosphorous acetyl-L-aspartate), recombinant interferon alpha (rlFN?), and fluorouracil (5-FU) infusion in advanced squamous cell carcinoma of the head and neck (SCCHN): p53 immunostain predicts prognosis. Proc Am Soc Clin Oncol 15:883A, 1996.
  15. Bonin SF, Qian C, Russell AH, Coia LR, Paris KJ, Flam MS, Sauter ER: Overexpression of p53 protein is associated with decreased local disease-free survival in patients treated with chemoradiation for anal canal cancer: A report of RTOG 87-04. Int J Rad Oncol Biol Phys 36:104A, 1996.
  16. Sauter E, Zarghami N, Diamandis E, Engstrom P: PSA levels in nipple aspirate fluid are upregulated by progesterone. Proc Am Assoc Cancer Res 38:1767A, 1997.
  17. Sauter E, Nesbit M, Herlyn M: Vascular endothelial growth factor (VEGF) is a marker of disease progression in head and neck cancer. Proc Am Assoc Cancer Res 38:2217A, 1997.
  18. Liu S, Clapper ML, Sauter ER, Feldman R, Levin L, Engstrom PF, Klein-Szanto, AJP: Markers of cell proliferation in normal human oral epithelia and leukoplakias: baseline data for chemoprevention studies. Proc Am Assoc Cancer Res 38:3539A,1997.
  19. Diamandis EP, Zarghami N, Grass L, Sauter ER: Prostate specific antigen levels in serum during the menstrual cycle: possible regulation by progesterone. Annual Mtg Endocrine Society 79:385A, 1997.
  20. Liu SC, Clapper ML, Sauter ER, Feldman R, Levin L, Engstrom PF, Klein-Szanto AJP. Image analysis of cyclin D1 and p53 expression in oral epithelia and premalignant lesions. 11th Intl Congress on Diagnostic Quantitative Pathology, 1997.
  21. Sauter ER, Daly MB, Engstrom PF, Melegos DN, Diamandis EP: IGFBP-3 expression in Nipple Aspirate Fluid (NAF) Correlates with Breast Cancer Risk. Proc Am Assoc Cancer Res 39:1590A, 1998.
  22. Sauter ER, Atillasoy ES, Gallagher PM, Binder RL, Goodrow TL, Montone KT, Klein-Szanto AJP, Seykora JT, Whiteley LO, Herlyn M: Carcinogenesis and p53 expression in human skin grafted to RAG-1 mice. Proc Am Assoc Cancer Res 39:156A, 1998.
  23. Rheinwald JG, Benwood JA, Palanisamy A, Feldman RS, Sauter ER: Keratinocyte cell lines exhibiting EGF-Independence and extended replicative lifespan cultured from human dysplastic oral epithelial lesions. Proc Am Assoc Cancer Res 39:3324A, 1998.
  24. Cheffetz S, Sauter ER, Herlyn M, Feldman RS. Adenovirus-mediated suppression of cyclin D1 in human SCCA. Annual Meeting IADR, 1998.
  25. Rheinwald J, Palanisamy A, Benwood J, Feldman R, Sauter E: Premalignant human keratinocytes exhibiting extended replicative lifespans and EGF-independence cultured from dysplastic oral epithelial lesions. Annual Meeting International Investigative Dermatology, 1998.
  26. Sauter ER, Ehya H, Babb J, Diamandis EP, Daly M, Klein-Szanto AJP, Sigurdson E, Hoffman J, Malick J, Engstrom PF: Nipple aspirate fluid (NAF) cytology predicts residual disease after diagnostic biopsy. Proc Am Assoc Cancer Res 39:1560A, 1998.
  27. Watson JC, Klein-Szanto AJP, Ridge JA, Friedman CD, Babb JS, Sauter ER. Progression to invasive head and neck cancer is associated with vascular endothelial growth factor (VEGF) overexpression. 51st Annual Cancer Symposium, Soc of Surg Oncol, 1998.
  28. Woodson K, Brotzman M, Goodrow T, Sauter E, Cleveland D, Mohr R, Klein-Szanto A, Trock B. Predicting p53 mutation status in head and neck cancers. Cancer Epidemiol Biomarkers Prev, 8:195, 1999.
  29. Sauter ER, Klein-Szanto AJP, Engstrom PF, Feldman R, Levin L, Clapper ML. DFMO in oral dysplastic leukoplakia. 23rd Annual Mtg Am Soc Prev Oncol, Houston, TX, March 14-16, 1999.
  30. Sauter ER, Litwin, S, Ridge JA. Profound response with antisense cyclin D1 in a human squamous cancer xenograft model. 52nd Annual Cancer Symposium, Soc Surg Oncol, 1999.
  31. Brotzman M, Goodrow T, Klein-Szanto A, Kisielewski A, Ridge A, Sauter E, Sessions R, Cleveland D, Mohr R, Trock B. Vitamin supplement use and p53 mutations in head and neck cancer. Proc Am Assoc Cancer Res 40:4126A, 1999.
  32. Obiezu CV, Black NH, Magklara A, Levesque MA, Sutherland DJA, Tindall DJ, Young CYF, Sauter ER, Diamandis EP. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumors and in normal breast secretions. Proc Am Assoc Cancer Res 40:2505A, 1999.
  33. Sauter ER, Nesbit M, Litwin S, Klein-Szanto AJP, Herlyn M. Combination gene therapy to treat human malignant melanoma. Proc Am Assoc Cancer Res 40:3951A, 1999.
  34. Mitchell G, Sauter ER, Sibley PEC, Wilson P, Trott PA, Eeles RA. Nipple aspiration fluid (NAF). The new mammography? 1st Ntl showcase of the Best of British Science, House of Commons, London, 15th March, 1999.
  35. Mitchell G, Eeles RA, Sauter ER, Sibley PA, Wilson P. Prostate specific antigen in nipple aspirate fluid (NAF): relationship with the menstrual cycle. 22nd Annual San Antonio Breast Cancer Symposium, 1999.
  36. Sauter ER, Litwin S, Engstrom PF, Diamandis A, Khosravi J, Diamandis EP. Fragmented insulin-like growth factor binding protein-3 is inversely associated with breast cancer risk. Proc Am Assoc Cancer Res 41:3661A, 2000.
  37. Tichansky DS, Nesbit M, Litwin S, Herlyn M, Sauter ER. Combined gene therapy in human melanoma. 53rd Annual Meeting, Society of Surgical Oncology, 2000.
  38. St. John LS, Sauter ER, Herlyn M, Litwin S, Adler-Storthz K. Endogenous p53 gene status predicts response of human squamous cell carcinomas to wild-type p53. J Dental Res 79:167, 2000.
  39. Krassenstein R, Sauter E, Battagli C, Ehya H, Klein-Szanto A, Cairns P. Detection of breast cancer in nipple aspirate fluids by methylation specific PCR. Proc Am Assoc Cancer Res 42:55A, 2001.
  40. Sauter ER, Chervoneva I, Diamandis A, Khosravi J, Litwin S, Diamandis E. NAF biomarkers predict premenopausal and serum biomarkers predict postmenopausal breast cancer risk. Proc Am Assoc Cancer Res 42:59A, 2001.
  41. Tichansky DS, Diamandis EP, Chervoneva I, Sauter ER. Nipple aspirate fluid (NAF), serum and tissue in the evaluation of breast cancer risk. 54th Annual Meeting, Society of Surgical Oncology, 17A, 2001.
  42. Tichansky DS, Nesbit M, Liu Z-J, Palazzo J, Herlyn M, Sauter ER. FGF-BP expression changes with disease progression in clinical and experimental human squamous epithelium Proc Am Assoc Cancer Res 42:4327A, 2001.
  43. Wickstrom E, Tian X, Thakur ML, Rao PS, Qin W, Sauter ER. Oncogene mRNA imaging with [99Tc(VII)]-PNA-peptides. International Conference on RNA as Therapeutic and Genomics Target Novosibirsk Institute of Bioorganic Chemistry, Akademgorodok, Russia, September 2001.
  44. Sauter ER, Ehya H, Mammen A, Klein G. Nipple aspirate fluid (NAF) cytology and pathologic parameters predict residual breast cancer and nodal spread after excisional biopsy. Breast Cancer Research and Treatment 69:328A, 2001.
  45. Zhu W, Rao PS, Sauter E, Thakur ML. VPAC1 receptors are abundant on human breast cancer cells (hBCC). Annual Mtg., Society for Nuclear Medicine, 2001.
  46. Sauter ER. Nipple aspirate fluid (NAF) to identify markers of breast cancer risk. Proceedings, 6th World Congress on Advances in Oncology, Int J Molec Med 8(S1): 187A, 2001.
  47. Thakur ML, Wickstrom E, Tian X, Rao PS, Qin W, Sauter ER. Tc-99m-chelator-PNA-peptides for imaging oncogene mRNA. "Imaging in 2020" Symposium, Jackson Hole, WY, 2001.
  48. Sauter ER, Rao PS, Tian X, Wenyi Qin W, Thakur ML, Wickstrom E. Imaging oncogene expression in breast lesions with Tc-99m-PNA-peptides. AACR Special Conference on Molecular Imaging, Lake Buena Vista, FL, January 23-27, 2002.
  49. Zhu W, Qin W, Sauter ER. Nuclear and mitochondrial genomic instability in matched breast cancer and normal tissue. Proc Am Assoc Cancer Res 93:1451A, 2002.
  50. Qin W, Zhu W, Hsuing R, Klein G, Sauter ER. High levels of basic fibroblast growth factor (bFGF) in nipple aspirate fluid (NAF) are associated with breast cancer. Proc Am Assoc Cancer Res 93:4551A, 2002.
  51. Qin W, Zhu W, Sauter ER. Nipple aspirate fluid (NAF) as source material for the molecular diagnosis of breast cancer. Proc Am Assoc Cancer Res 93:4553A, 2002.
  52. Wickstrom E, Tian X, Rao PS, Qin W, Thakur ML, Sauter ER. Imaging Oncogene mRNA in Mice with Tc-99m-peptide-PNA. DOE Workshop in Imaging Gene Expression In Vivo, Cambridge, MA, Feb. 10-12, 2002.
  53. Rao PS, Tian X, Qin W, Thakur ML, Sauter ER, Wickstrom E. Imaging oncogene expression in breast tumors with Tc-99m-PNA peptides. Proc Am Assn Cancer Res 93:707A, 2002.
  54. Iacono R, Flynn JT, Sauter ER. Celecoxib In Women At Increased Breast Cancer Risk. Department of Defense Breast Cancer Research Program Mtg, 2002.
  55. Garofalo C, Zhu W, Morelli C, Sauter ER, Surmacz E. Leptin (obesity protein) in nipple aspirates and breast cancer risk. Department of Defense Breast Cancer Research Program Mtg, 2002.
  56. Zhu W, Josyula S, Thompson P, Sauter ER. Mitochondrial Mutations In Tumors And In Nipple Aspirate Fluid Collected From The Same Breast. Department of Defense Breast Cancer Research Program Mtg, 2002.
  57. Ehya H, Iacono R, Klein-Szanto AJP, James J, Daly MB, Sauter ER. Breast Cancer Biomarkers In Nipple Aspirates From Women Treated With Estrogen Receptor Blockers. Department of Defense Breast Cancer Research Program Mtg, 2002.
  58. Thakur ML, Sauter E, Rao PS, Zhu W, Tian X, Qin W, Wickstrom E. Tc99m-PNA-Peptide: Imaging Oncogene Expression in Breast Lesions. J Nuclear Medicine 43:124P, 2002.
  59. Sauter ER, Garofalo C, Hewett J, Surmacz E. Leptin expression in breast nipple aspirate fluid (NAF) is influenced by body mass index (BMI) and menopausal status. 2002 San Antonio Breast Cancer Conference.
  60. Sauter ER. Association of uPA, PAI-1 and uPAR in nipple aspirate fluid (NAF) with breast cancer. Annual Mtg, Society of Surgical Oncology, 2003.

Non-peer Reviewed Publications

  1. Sauter ER. Intraductal approaches to aid in the early detection of breast cancer. Oncology Review, Ellis Fischel Cancer Center, Fall 2002.

View all publications by Dr. Sauter


Top
0
 ·  About Our Research
 ·  Clinical Trials
 ·  For Patients & Families
 ·  Research Lab
 ·  Research Positions
 ·  Our Team
 ·  Publications
 ·  Glossary
 ·  Links
 ·  Contact Us
 ·  Breast Cancer Lab Home
0
 ·  Surgical Oncology
 ·  Department of Surgery
 ·  Surgery Research Conferences
 ·  Surgery Research
 ·  Health Care Resources
 ·  Your Health: Breast Cancer
0
 ·  University of Missouri Health Care
 ·  MU School of Medicine
 ·  Ellis Fischel Cancer Center
 ·  University of Missouri



Breast Cancer Prevention & Early Detection Laboratory
Edward R. Sauter, MD, PhD

Division of Surgical Oncology
Department of Surgery
University of Missouri Health Care

musurgery.org
I-Net Administrator | Network Manager
2000 © Curators of the University of Missouri-Columbia
DMCA and Other Copyright information
An Equal Opportunity/ADA Institution